GSK is consolidating two of its influenza vaccine manufacturing sites into one, leaving hundreds of jobs at risk.  | GSK is ...

GSK plc (NYSE:GSK) plans to close its vaccine manufacturing facility in Dresden, Germany, by summer 2027, putting 641 jobs at risk. The decision reflects declining demand for traditional egg-based flu ...

GSK is consolidating its vaccine manufacturing operations to one site—located in Canada—amid what a spokesperson said is “decreasing demand” for egg-based flu shots.

GSK (LSE:GSK) agreed to acquire Chimagen's trispecific T cell-engager candidate for multiple myeloma, expanding its blood cancer research portfolio. The drug asset is described by the parties as a ...

An industrial brawl could be brewing at GlaxoSmithKline. Hundreds of GSK employees in the U.K. have voted to strike against a “derisory” pay raise offer from the British Big Pharma, local labor union ...

While the United Kingdom feted President Trump in his second state visit, GSK said Wednesday it will spend $30 billion over the next five years to build new manufacturing and research facilities ...

The FINANCIAL — GSK on April 18 opens a £56 million state of the art manufacturing facility, creating 150 new jobs in the UK, in response to demand for GSK’s portfolio of respiratory medicines ...

GSK plc announced Wednesday that it will invest roughly $1.2B to build a new facility for pharmaceutical manufacturing and research and development in Upper Merion, Pennsylvania, as well as to upgrade ...

GSK plc (NYSE:GSK) on Wednesday announced plans to invest $30 billion across the United States in research and development and supply chain infrastructure over the next five years. The update includes ...

(RTTNews) - British drug major GSK plc (GSK, GSK.L) announced Wednesday its plans to invest $30 billion across the United States in research and development and supply chain infrastructure over the ...